is closed

(deadline: FEBURARY 28TH)



  1. The title of the abstract must be entered in CAPITAL LETTERS.
  2. The text must fit entirely in the rectangular space allotted on this form.
  3. The lines must be single-spaced.
  4. All fieldsmust be entered.
  5. Personal data refers to those of the First Author.
  6. The name of the First Author must be repeated in the “Authors” field.
  7. All authors’ names and first author’s name must be entered as follows: Surname. Name initials  (e.g. Smith J).
  8. In the case of more than one affiliation please indicate in the proper field, following the order of the authors: (e.g. Authors: Smith J1, Lewis F2, Burton A3. Affiliation: 1-Saint Paul Hospital, 2-Cambridge University, 3-Paris University).
  9. For Original Research the abstract should be structured and include the following sections:
    a) Introduction: maximum 500 characters
    b) Methods: maximum 750 characters
    c) Results: maximum 750 characters
    d) Conclusion(s): maximum 500 characters
  10. For Case reportsthe abstract should include the following sections:
    a) Introduction: maximum 500 characters
    b) Case description: maximum 1500 characters
    c) Conclusion(s): maximum 500 characters
  11. Please note that, if you do not receive an email confirming your submissionafter filling in the Abstract form, it means that your abstract has not been submitted correctly. Please, repeatthe operation.


The decision on acceptance of the abstract will be made by the scientific committee by April 2017.

After acceptance of the abstract, at least one of the authors must be registered to the conference, or otherwise the contribution will be declined.

Please indicate whether your abstract is being submitted for poster presentation, or if you wish it to be considered for oral presentation. In all cases, the scientific committee will inform you whether it has been accepted for oral presentation, poster presentation, or whether it has not been accepted for presentation.